Cadrenal (CVKD) Fundamental Analysis: Revenue, Earnings & Valuation

9.06 / 10

Outperform

Fundamentally, CVKD scores 9.1/10, outperforming peers. Interest coverage (15.6x) and revenue‑to‑market value are strong, inventory turnover is healthy, while long‑term debt to working capital and a 100% current‑liabilities ratio raise concerns.

Analysis Checks(6/10)

Revenue-MV

Value-0.28

Score3/3

Weight162.81%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value78.03

Score2/3

Weight2.24%

1M Return0.13%

Inventory turnover ratio

Value47.95

Score2/3

Weight-18.56%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value100.00

Score0/3

Weight-68.79%

1M Return-4.96%

PB-ROE

Value5.29

Score0/3

Weight54.84%

1M Return2.74%

Long-term debt to working capital ratio (%)

Value26.96

Score0/3

Weight-70.73%

1M Return-4.75%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-18.87%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value92.19

Score2/3

Weight0.91%

1M Return0.05%

Cost of sales ratio (%)

Value70.31

Score2/3

Weight-17.84%

1M Return-1.13%

Asset-MV

Value-0.49

Score0/3

Weight73.99%

1M Return4.00%

Is CVKD fundamentally strong?

CVKD scores 9.06/10 on fundamentals and holds a Discounted valuation at present. Backed by its -260.11% ROE, 0.00% net margin, -0.89 P/E ratio, 4.30 P/B ratio, and 23.94% earnings growth, these metrics solidify its Outperform investment rating.